Harbin Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 24.7% in 2022

Harbin Pharmaceutical Group Co.,Ltd. (哈药集团股份有限公司) (600664.SH) reported a net profit of 511.1 million yuan in 2022, up 24.7% year-on-year.

Meanwhile, the company posted 13.8 billion yuan in revenue, up 7.9% year-on-year.

At the end of the reporting period, it had 13.4 billion yuan in total assets and 8.5 billion yuan in total liabilities, with a liability-to-asset ratio of 63.2%.